139 related articles for article (PubMed ID: 7642974)
1. Intraduodenal cholecystokinin octapeptide (CCK-8) can stimulate pancreatic secretion in the calf.
Zabielski R; Onaga T; Mineo H; Kato S; Pierzynowski SG
Int J Pancreatol; 1995 Jun; 17(3):271-8. PubMed ID: 7642974
[TBL] [Abstract][Full Text] [Related]
2. Effect of neural blockades, gastrointestinal regulatory peptides, and diversion of gastroduodenal contents on periodic pancreatic secretion in the preruminant calf.
Zabielski R; Kiela P; Onaga T; Mineo H; Gregory PC; Kato S
Can J Physiol Pharmacol; 1995 Nov; 73(11):1616-24. PubMed ID: 8789416
[TBL] [Abstract][Full Text] [Related]
3. Effects of intraduodenal administration of tarazepide on pancreatic secretion and duodenal EMG in neonatal calves.
Zabielski R; Leśniewska V; Borlak J; Gregory PC; Kiela P; Pierzynowski SG; Barej W
Regul Pept; 1998 Nov; 78(1-3):113-23. PubMed ID: 9879754
[TBL] [Abstract][Full Text] [Related]
4. Effect of L364718 on interdigestive pancreatic exocrine secretion and gastroduodenal motility in conscious sheep.
Onaga T; Mineo H; Kato S
Regul Pept; 1997 Jan; 68(2):139-46. PubMed ID: 9110386
[TBL] [Abstract][Full Text] [Related]
5. Local versus peripheral blood administration of cholecystokinin-8 and secretin on pancreatic secretion in calves.
Zabielski R; Onaga T; Mineo H; Pierzynowski SG; Kato S
Exp Physiol; 1994 May; 79(3):301-11. PubMed ID: 8074843
[TBL] [Abstract][Full Text] [Related]
6. Plasma secretin fluctuates in phase with periodic pancreatic secretion and the duodenal migrating myoelectric complex in calves.
Zabielski R; Terui Y; Onaga T; Mineo H; Kato S
Res Vet Sci; 1994 May; 56(3):332-7. PubMed ID: 8073185
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent duodenal stimuli via vagal afferent fibres in the rat.
Li Y; Owyang C
J Physiol; 1996 Aug; 494 ( Pt 3)(Pt 3):773-82. PubMed ID: 8865073
[TBL] [Abstract][Full Text] [Related]
8. Neurohormonal mechanism of pancreatic exocrine secretion stimulated by sodium oleate and L-tryptophan in dogs.
Jo YH; Lee YL; Lee KY; Chang TM; Chey WY
Am J Physiol; 1992 Jul; 263(1 Pt 1):G12-6. PubMed ID: 1636708
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
Shiratori K; Watanabe S; Takeuchi T
Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
[TBL] [Abstract][Full Text] [Related]
10. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
11. Mediators of exocrine pancreatic secretion induced by intraduodenal application of bile and taurodeoxycholate in man.
Riepl RL; Reichardt B; Rauscher J; Tzavella K; Teufel J; Lehnert P
Eur J Med Res; 1997 Jan; 2(1):23-9. PubMed ID: 9049590
[TBL] [Abstract][Full Text] [Related]
12. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
Romański KW
J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220
[TBL] [Abstract][Full Text] [Related]
13. Dose-related effects of cholecystokinin octapeptide administered during various phases of the migrating motor complex on small-intestinal motility in sheep.
Romański KW
Acta Vet Hung; 2009 Dec; 57(4):495-508. PubMed ID: 19897454
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats.
Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
Pancreas; 2002 Apr; 24(3):269-75. PubMed ID: 11893935
[TBL] [Abstract][Full Text] [Related]
15. Bovine pancreatic secretion in the first week of life: potential involvement of intestinal CCK receptors.
Zabielski R; Morisset J; Podgurniak P; Romé V; Biernat M; Bernard C; Chayvialle JA; Guilloteau P
Regul Pept; 2002 Feb; 103(2-3):93-104. PubMed ID: 11786148
[TBL] [Abstract][Full Text] [Related]
16. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
17. Latency of pancreatic fluid secretory response to intestinal stimulants in the dog.
Singer MV
J Physiol; 1983 Jun; 339():75-85. PubMed ID: 6310094
[TBL] [Abstract][Full Text] [Related]
18. Effects of duodenal alkalinization on pancreatic secretion.
Takeshima T; Adler M; Nacchiero M; Rudick J; Dreiling DA
Am J Gastroenterol; 1977 Jan; 67(1):54-62. PubMed ID: 851106
[TBL] [Abstract][Full Text] [Related]
19. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
[TBL] [Abstract][Full Text] [Related]
20. Atropine abolishes the potentiation effect of secretin and cholecystokinin-octapeptide on exocrine pancreatic secretion in humans.
You CH; Chey WY
Pancreas; 1988; 3(1):99-103. PubMed ID: 3362847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
